Xing Su

491 total citations
15 papers, 360 citations indexed

About

Xing Su is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Xing Su has authored 15 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Genetics and 7 papers in Cancer Research. Recurrent topics in Xing Su's work include Virus-based gene therapy research (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (4 papers). Xing Su is often cited by papers focused on Virus-based gene therapy research (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (4 papers). Xing Su collaborates with scholars based in China and United States. Xing Su's co-authors include Hui Peng, Xiaoyu Du, Yang Bai, Xu Ma, Shanwen Zhang, Dongming Li, Shaowen Xiao, Gang Xu, Yi Hu and Jingli Cao and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Virology and Scientific Reports.

In The Last Decade

Xing Su

15 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xing Su China	9	175	139	132	83	82	15	360
Nancy Kiviat United States	8	185 1.1×	169 1.2×	214 1.6×	34 0.4×	86 1.0×	9	416
Xiaoqian Tuo China	13	162 0.9×	73 0.5×	19 0.1×	72 0.9×	46 0.6×	20	356
Tammy Distad United States	4	163 0.9×	59 0.4×	15 0.1×	52 0.6×	108 1.3×	4	392
Roland Degenkolbe Singapore	5	153 0.9×	149 1.1×	82 0.6×	56 0.7×	69 0.8×	5	356
Anja Honegger Germany	7	285 1.6×	65 0.5×	34 0.3×	213 2.6×	70 0.9×	8	395
Alberto Cedro‐Tanda Mexico	11	238 1.4×	79 0.6×	34 0.3×	214 2.6×	50 0.6×	24	395
Pepijn G.J.T.B. Wijnands Netherlands	11	95 0.5×	342 2.5×	55 0.4×	24 0.3×	469 5.7×	12	564
Ivana Juko‐Pecirep Sweden	7	91 0.5×	79 0.6×	45 0.3×	88 1.1×	99 1.2×	7	308
Stefania Carrara Germany	10	126 0.7×	91 0.7×	27 0.2×	36 0.4×	62 0.8×	30	317
Christoph Lindner Germany	8	161 0.9×	67 0.5×	49 0.4×	48 0.6×	15 0.2×	15	286

Countries citing papers authored by Xing Su

Since Specialization

Citations

This map shows the geographic impact of Xing Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Su more than expected).

Fields of papers citing papers by Xing Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Su. The network helps show where Xing Su may publish in the future.

Co-authorship network of co-authors of Xing Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Su. A scholar is included among the top collaborators of Xing Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Su. Xing Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wang, Hongwu, Aijia Li, Xing Su, et al.. (2022). Proteomic and phosphorylated proteomic landscape of injured lung in juvenile septic rats with therapeutic application of umbilical cord mesenchymal stem cells. Frontiers in Immunology. 13. 1034821–1034821. 5 indexed citations

Jiang, Yining, et al.. (2022). The epithelial-mesenchymal transition of glioma cells promotes tissue factor expression via the miR200a/ZEB1 axis. Brain Research. 1778. 147782–147782. 6 indexed citations

Bai, Yang, Hui Peng, Xiaoyu Du, & Xing Su. (2019). Updates to the antitumor mechanism of oncolytic virus. Thoracic Cancer. 10(5). 1031–1035. 64 indexed citations

Su, Xing, Hong Wang, Xiaohong Zhou, et al.. (2018). Jembrana disease virus Vif antagonizes the inhibition of bovine APOBEC3 proteins through ubiquitin-mediate protein degradation. Virology. 519. 53–63. 5 indexed citations

Cheng, Jing, Xing Su, Lei Qiao, Chungang Zhai, & Wenqiang Chen. (2018). Circulating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris. Bioscience Reports. 38(5). 13 indexed citations

Wei, Ming, et al.. (2017). MiR125b-5p protects endothelial cells from apoptosis under oxidative stress. Biomedicine & Pharmacotherapy. 95. 453–460. 8 indexed citations

Zheng, Wenwen, Zhaolong Li, Hong Wang, et al.. (2017). Conserved Interaction of Lentiviral Vif Molecules with HIV-1 Gag and Differential Effects of Species-Specific Vif on Virus Production. Journal of Virology. 91(7). 3 indexed citations

Cao, Jingli, Lu Zhang, Jian Li, et al.. (2016). Up-regulation of miR-98 and unraveling regulatory mechanisms in gestational diabetes mellitus. Scientific Reports. 6(1). 32268–32268. 47 indexed citations

Li, Ying, Xueqin Wang, Lu Zhang, et al.. (2016). A SNP in pri-miR-10a is associated with recurrent spontaneous abortion in a Han-Chinese population. Oncotarget. 7(7). 8208–8222. 16 indexed citations

10.

Su, Xing, Yi Hu, Ying Li, et al.. (2015). The polymorphism of rs6505162 in the MIR423 coding region and recurrent pregnancy loss. Reproduction. 150(1). 65–76. 37 indexed citations

11.

Shi, Tian, Xing Su, Lu Qi, et al.. (2014). MiR-143 and rat embryo implantation. Biochimica et Biophysica Acta (BBA) - General Subjects. 1850(4). 708–721. 15 indexed citations

12.

Pan, Jianji, Shanwen Zhang, Shaowen Xiao, et al.. (2008). Effect of Recombinant Adenovirus-p53 Combined With Radiotherapy on Long-Term Prognosis of Advanced Nasopharyngeal Carcinoma. Journal of Clinical Oncology. 27(5). 799–804. 98 indexed citations

13.

Zhang, Shanwen, Shaowen Xiao, Yan Sun, et al.. (2006). 726. Clinical Trial of Recombinant Adenovirus-p53 (Gendicine) Combined with Radiotherapy in Nasopharyngeal Carcinoma Patients. Molecular Therapy. 13. S280–S280. 4 indexed citations

14.

Xu, Gang, et al.. (2005). Clinical study of recombinant adenovirus-p53 (Adp53) combined with hyperthermia in advanced cancer (a report of 15 cases). International Journal of Hyperthermia. 21(7). 631–636. 16 indexed citations

15.

Zhang, Shanwen, Shaowen Xiao, Changqing Liu, et al.. (2005). [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].. PubMed. 27(7). 426–8. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact